- Clear All
- Remove theImmunologyfilter Immunology
- Remove thePathologyfilter Pathology
- Remove theWildlifefilter Wildlife
- Remove theHumanfilter Human
- Remove theDrugs & vaccinesfilter Drugs & vaccines
- Remove thePet ownershipfilter Pet ownership
- Remove theDisaster preparedness & responsefilter Disaster preparedness & response
- Remove theEducationfilter Education
JAVMA news
Can veterinarians prevent the next pandemic?
The COVID-19 pandemic marks the third novel coronavirus outbreak of the 21st century. Unlike the viruses that cause severe acute respiratory syndrome…
JAVMA news
The risky business of global animal movement
Likely sources of another pandemic are being scrutinized like never before, including the global movement of animals via international trade and…
JAVMA news
The case of the wildly varying degrees of toxicity in wildlife
A real doctor treats more than one species. At least that's how one of veterinary medicine's favorite sayings goes—and there's a lot of truth to it,
JAVMA news
NIH awards $17M to research emerging infectious diseases
The National Institute of Allergy and Infectious Diseases announced in August the creation of the Centers for Research in Emerging Infectious…
JAVMA news
1975 - 1985
In the decade that saw the glitter fade from disco, JAVMA carried articles that were of practical value—reports of new techniques and procedures, drug…
JAVMA news
COVID vaccine an immunological moonshot
Developing and distributing a vaccine for a novel coronavirus that has killed more than a million people globally has the potential of becoming the…
JAVMA news
Finding a future for osteosarcoma patients
Ana M. Cilursu, MD, lost three Rottweilers in a row to bone cancer.
JAVMA news
Vaccine holds promise for treating osteosarcoma in dogs
Veterinarians in the audience wanted to know when they could get their hands on the new treatment. Dr. Sue Ettinger, a veterinary oncologist, had…
JAVMA news
A glimmer of hope for a fatal feline disease
Controlling risk factors for feline infectious peritonitis is difficult, while new antiviral drugs show great promise